Generic placeholder image

Current Drug Safety


ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Case Report

Use of Paediatric Xylometazoline Nasal Drop is not a Child’s Play in Hypertensive Patients on Bisoprolol: A Case Report

Author(s): Hira Bhalla*, Abhishek Gupta and Tejas Patel

Volume 16, Issue 3, 2021

Published on: 13 January, 2021

Page: [293 - 295] Pages: 3

DOI: 10.2174/1574886316666210114094856

Price: $65


Background: Xylometazoline, a sympathomimetic agent, is considered safe in hypertensive patients as a relief measure for nasal congestion with intranasal application.

Case Report: In the present case, a 58-year old male patient, having ischemic heart disease, controlled hypertension on telmisartan and bisoprolol, experienced hypertensive urgency in a span of two hours of intranasal administration of the paediatric formulation of xylometazoline.

Conclusion: The interaction with bisoprolol should be kept in mind while using xylometazoline.

Keywords: Xylometazoline, sympathomimetic agent, bisoprolol, interaction, hypertensive urgency, intranasal.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy